adherence of circulating monocytes to activated endothelial cells. Adherent monocytes subsequently migrate into the subendothelial space in response to locally produced chemoattractant molecules, where they further differentiate into macrophages and take up excess retained and modified plasma lipoproteins 1, 2) . The modified lipoproteins taken up by macrophage scavenger receptors are delivered to lysosomes, where their cholesterol ester (CE) content is hydrolyzed to free cholesterol (FC) and fatty acids at acidic pH. Unlike the low density lipoprotein (LDL) receptor gene, which contains a sterol regulatory element in the 5' region, the genes of scavenger receptors lack sterol regulatory elements and are not down-regulated by cholesterol loading; therefore, prolonged exposure to modified lipoprotein results in excess FC, which undergoes re-esterification by acyl coenzyme A:acylcholesterol transferase 1 (ACAT-1). Fatty acid sterol esters are stored in cytoplasmic lipid droplets that bulge out from the endoplasmic reticulum (ER). These macrophages are often referred to as 'foam cells' because of the foamy appearance of the cytoplasmic
Intracellular Cholesterol Homeostasis in Macrophages
Macrophages maintain homeostasis within multicellular organisms by their multifaceted roles (e.g. scavenging apoptotic cells, and innate and adaptive immunity) under physiological conditions; however, homeostasis can be disturbed under some pathological conditions, such as atherosclerosis, obesity and rheumatic arthritis. In this article, we will focus on dysregulated homeostasis of cholesterol in macrophages having a causative role in atherosclerotic diseases.
From early fatty-streak lesions to advanced plaques, macrophage-derived foam cells are integral to the development and progression of atherosclerosis. The formation of fatty streaks is initiated by the CE inclusions. The esterification of FC into CE by ACAT-1 is opposed by neutral cholesterol ester hydrolase (nCEH), which catalyzes CE hydrolysis at neutral pH. The hydrolysis of intracellular CE is the initial step of reverse cholesterol transport (RCT) 3) , which is critical for maintaining cellular cholesterol homeostasis, since mammalian cells do not have the ability to degrade the sterol ring and must export excess cholesterol via extracellular acceptor-mediated cholesterol efflux. Several different pathways of cholesterol efflux have been described, such as active cholesterol efflux via ATP-binding cassette transporters, aqueous diffusion, 27-hydroxylation, efflux associated with apoE secretion, and scavenger receptor-BI-mediated efflux 4) . Both ATP-binding cassette transporter A1 (ABCA1) and ATP-binding cassette transporter G1 (ABCG1) are responsible for the majority of the pathway, and apoE secretion could be linked to ABCA1/ ABCG1-mediated cholesterol efflux [5] [6] [7] ; however, the molecular links between intracellular CE hydrolysis and cholesterol efflux have yet to be elucidated.
Hydrolysis of CE in macrophages has been known for over 40 years 8) , and nCEH plays a critical role in macrophage cholesterol homeostasis; however, the molecule(s) responsible for the nCEH reaction have long been a missing piece in our understanding of macrophage cholesterol homeostasis.
Candidate Genes for nCEH Activity in Macrophages
Previously, it was believed that hormone-sensitive lipase (LIPE) was responsible for nCEH activity in macrophages [9] [10] [11] . LIPE is an intracellular neutral lipase that catalyzes the hydrolysis of triacylglycerol, diacylglycerol, monoacylglycerol, and CE as well as other lipids. Although LIPE was initially identified as an adipose-specific lipase 12) , it has since been shown that LIPE is expressed in a wide variety of organs and cells, including the heart, skeletal muscle, adrenal glands, testes, ovaries, pancreatic -cells, liver, intestine and macrophages [13] [14] [15] [16] . However, phenotypic analyses of Lipe-deficient mice generated by several laboratories, including ours, have suggested the redundancy of lipases in macrophages as well as in adipose tissue. Neither acylglycerol hydrolysis in adipose tissues nor neutral CE hydrolysis in macrophages was completely abolished by Lipe deficiency [17] [18] [19] . Zechner and his colleagues, as well as other groups, discovered another adipose-specific lipase, adipose triglyceride lipase (ATGL, PNPLA2, also known as desnutrin, calciumindependent phospholipase A2 ) [20] [21] [22] , that together with LIPE was shown to be responsible for almost all triglyceride hydrolase activity in adipose tissue 23) . In contrast, the primary enzyme catalyzing nCEH activity in macrophages remains to be elucidated. Cholesterol ester hydrolase (CEH) 24) , which is identical to human liver carboxylesterase 1/macrophage serine esterase 1 (CES1, hCE-1, HMSE1) 25, 26) and is a human ortholog of triacylglycerol hydrolase (TGH) 27) , was proposed as a promising candidate of nCEH in macrophages. It was reported that macrophage-specific overexpression of CEH driven by the type A scavenger receptor (SRA) promoter protected against dietinduced atherosclerosis in LDL receptor-deficient mice 28) ; however, the effects of loss-of-function of CEH on nCEH activity in macrophages have not been reported. Furthermore, the mouse ortholog of CEH, TGH, is expressed at low levels in mouse peritoneal macrophages (MPMs) 29) and possesses negligible nCEH activity 30) ; therefore, circumstantial evidence suggests the existence of other nCEH(s) in macrophages.
To identify nCEHs in macrophages, we utilized a bioinformatics approach. We screened a gene database for murine and human proteins with homology to structures preserved in known lipases, specifically, the / -hydrolase fold, the GXSXG active serine motif and the HG dipeptide motif. Through this screening, we identified neutral cholesterol ester hydrolase 1 (NCEH1) 29) , which is also known as KIAA1363/ AADACL1 31) , as a candidate of nCEH in macrophages. In contrast to the low level expression of CEH in macrophages, Nceh1 is robustly expressed in MPMs as well as in atherosclerotic lesions. Its overexpression inhibits the accumulation of CE in THP-1 macrophages, and knock-down of Nceh1 by short interference RNA significantly reduces nCEH activity in MPMs 29) ; therefore, Nceh1 appears to play an important role in CE hydrolysis in MPMs.
The murine gene for Nceh1 encodes a 408-amino acid protein with a calculated molecular mass of 45.7 kDa. Nceh1 has three N-glycosylation sites, and the molecular mass is 40 kDa after removal of glycosylation 32) . NCEH1 contains domains that are present in LIPE, such as the catalytic core domain and lipid-binding domain, but lacks the regulatory domain of LIPE 13, 29) . NCEH1 is a type transmembrane protein tethered to the ER membrane by its N-terminus with the rest of the protein containing the catalytic domain residing in the ER lumen 32) . In murine tissues, expression of Nceh1 mRNA is most abundant in the kidney followed by the adrenal gland, heart, brain and liver 29) . In addition to hydrolyzing CE, NCEH1 may also catalyze the hydrolysis of 2-acetyl monoalkylglycerol 33) and triacylglycerol 29) . Human NCEH1 is highly expressed in human macrophages and atheromatous plaques, and becomes up-regulated during macrophage differentiation 34) . Loss-of-function as well as gain-of-function studies revealed that NCEH1 plays a critical role in the hydrolysis of CE in human macrophages as compared with LIPE or CES1.
The Physiological role of NCEH1 and LIPE in foam Cell Formation and Atherogenesis
To gain insight into the physiological roles of Nceh1, we took advantage of gene targeting. Nceh1 was responsible for approximately 50% of nCEH activity in MPMs. Upon exposure to acetylated low density lipoprotein (acLDL), the intracellular CE content was increased by 50%, and cholesterol efflux was decreased by 35% in Nceh1-deficient MPMs. In addition to the importance of Nceh1 in the prevention of foam cell formation in vitro, Nceh1 deficiency also accelerated the progression of atherosclerosis 2-fold in Apoe-deficient mice without affecting their serum lipid profile 35) . These data demonstrated that Nceh1 plays a key role in opposing foam cell formation and atherosclerotic lesion development.
We next generated Nceh1/Lipe double-deficient mice to compare cholesterol trafficking of macrophages lacking Lipe, Nceh1, or both. Each enzyme made a similar contribution to nCEH activity, accounting for nearly 90% when combined. The ablation of each enzyme additively reduced cholesterol efflux and promoted foam cell formation, although the impact of Lipe on foam cell formation and atherogenesis appeared to be less than that of Nceh1 35) . Importantly, the combined deficiency of Nceh1 and Lipe almost completely abolished nCEH activity. It is also noteworthy, however, that the combined deficiency of Nceh1 and Lipe reduced cholesterol efflux by only 30-40%. This discrepancy may be explained if we assume that cholesterol efflux occurs from two distinct pools: CE in lipid droplets and FC mainly in the plasma membrane. The lack of hydrolysis of CE by Nceh1 and Lipe deficiency may impair the mobilization of cholesterol only from one pool, thus only partially affecting total cholesterol efflux. In contrast, deficiency of both ABCA1 and ABCG1 was reported to result in almost complete ablation of cholesterol efflux [5] [6] [7] , probably because mobilization of cholesterol from both pools is impaired.
To directly assess the roles of Nceh1 and Lipe in atherogenesis in vivo, we used bone marrow (BM) transplantation to create macrophage-selective knockouts in LDL receptor knockout mice. Nceh1 / ; Lipe / BM recipients developed atherosclerosis faster than the control and singly-deficient BM recipients. These observations demonstrated that together with Lipe, Nceh1 plays a major role in neutral cholesterol ester hydrolysis in macrophages. Thus, Nceh1 and Lipe seem to be the pieces missing from the puzzle of macrophage cholesterol homeostasis (Fig. 1) 
35)
.
Future Directions
Since CE is stored almost exclusively in lipid droplets, it is believed that the enzyme(s) that mediate the hydrolysis of CE in lipid droplets are located on or in close proximity to lipid droplets. Indeed, substantial amounts of LIPE are present in the cytoplasm, and lipolytic stimulation, such as the activation of PKA, induces the translocation of LIPE to lipid droplets 36) . From this standpoint, it is rather surprising that NCEH1, which is a microsomal enzyme, mediates the hydrolysis of CE in lipid droplets 32) . Although the precise mechanism is largely unknown, current studies have revealed a close association of lipid droplets with the ER. First, in adipocytes, lipid droplets originate from the cytoplasmic leaflet of the ER membrane 37) and are surrounded by the ER. Second, lipid droplets possess active vesicular trafficking machinery, as indicated by the presence of Rab18 38) , which also links lipid droplets to the ER 39) . ACAT1, which resides in the ER, synthesizes CE in lipid droplets budding from the cytoplasmic leaflets of the ER in macrophages. CE in the lipid droplets is continuously undergoing a futile cycle of hydrolysis, transport of the sterol to the ER for esterification, and transport back to lipid droplets. NCEH1 may alter CE content in lipid droplets by disrupting this cycle. Interestingly, serial reports suggested that ACAT-1 acts on small vesicles generated from the ER, especially upon cholesterol loading. NCEH1 might also co-localize to the vesicles and catalyze CE hydrolysis 40, 41) . In addition, many lipolytic enzymes require associating molecules in order to allow efficient access of the substrate to their catalytic sites (e.g. perilipin for LIPE 42) and ATGL 43) , CGI-58 for ATGL 44) ). NCEH1 may also interact with lipid droplets via unknown associating molecules.
Currently, we cannot clearly define the separate functions of NCEH1 and LIPE, although both can catalyze the hydrolysis of CE and prevent foam cell formation. While NCEH1 is an ER protein and LIPE is a cytosolic protein, there is no obvious evidence as to whether NCEH1 and LIPE act redundantly or have distinct roles. The interacting molecules that regulate NCEH1 activity might also reveal unique roles of NCEH1 and LIPE.
The therapeutic potential of NCEH1 for the treatment or prevention of atherosclerotic diseases deserves further scrutiny. Although we have reported that adenovirus-mediated overexpression of NCEH1 decreases foam cell formation in vitro, in vivo evidence, such as overexpression of NCEH1 using transgenic technology and pharmacological activation using a chemical screening technique should be obtained. Overexpression of macrophage LIPE in vivo using transgenic technology gave a somewhat complicated result. Overexpression of LIPE resulted in a paradoxical increase in atherosclerotic lesion development 11) , which could be reversed by the concomitant co-overexpression of a cholesterol acceptor, apoA- 45) . In contrast to LIPE, overexpression of CEH was reported to reduce atherosclerosis in LDL receptordeficient mice 28) . Overactivation of NCEH1 could advance atherosclerosis if excess cytotoxic end product, FC, is not efficiently removed. To consider NCEH1 as a therapeutic target, we should clarify the interplay between NCEH1-mediated CE hydrolysis and other pathways for cholesterol efflux, for example. Moreover, the regulatory mechanisms should be further investigated to identify transcriptional regulators and cofactor(s) necessary for full activation. We are currently exploring these issues.
NCEH1 is also expressed in several tissues, such as the kidney, adrenal glands and liver. LIPE has already been shown to catalyze CE hydrolysis in various tissues, such as the adrenal glands, liver and intestine 15, 16, 46) . The potential involvement of NCEH1 in other CE-metabolizing tissues awaits elucidation.
Conclusion
We have identified NCEH1 as a crucial enzyme in the protection against foam cell and atherosclerotic lesion development. Moreover, our data indicate that NCEH1 and LIPE are the two major nCEHs in murine macrophages. These findings provide important understanding of the pathophysiology of atherosclerosis and can be exploited to develop novel and The modified lipoproteins taken up by macrophage scavenger receptors are delivered to lysosomes, where their cholesterol ester (CE) content is hydrolyzed to free cholesterol (FC) and fatty acids by lysosomal acid lipase (LAL). Excess FC undergoes re-esterification by acyl coenzyme A:acylcholesterol transferase 1 (ACAT1), which resides in the endoplasmic reticulum. Fatty acid sterol esters are stored in a cytoplasmic lipid droplet that bulges from the endoplasmic reticulum. The actions of ACAT are opposed by CE hydrolysis at neutral pH. We have demonstrated that neutral cholesterol ester hydrolase 1 (NCEH1) and hormone-sensitive lipase (LIPE) are the major lipases responsible for neutral CE hydrolysis in macrophages. The resulting FC is effluxed via ABC transporters or other non-transporter pathways. 
